ALX Oncology Holdings, Inc. (ALXO)
1.47
+0.03
(+2.08%)
USD |
NASDAQ |
Dec 09, 16:00
1.41
-0.06
(-4.08%)
Pre-Market: 08:19
ALX Oncology Holdings EPS Diluted (Quarterly): -0.4133 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Prelude Therapeutics, Inc. | -0.2591 |
| Werewolf Therapeutics, Inc. | -0.3574 |
| Erasca, Inc. | -0.1079 |
| Immuneering Corp. | -0.3772 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.14M |
| Total Expenses (Quarterly) | 22.14M |
| Enterprise Value | 34.68M |
| Earnings Yield | -137.9% |
| Normalized Earnings Yield | -135.10 |